PeptideStack
5.2kquestions
20kanswers
220users

What interval makes sense for repeating LDL-C on cagrilintide?

Asked 17 Apr 2024Modified 2.0 years agoViewed 13k times
5

Conditions: LDL-C · cagrilintide.

I am trying to build something sustainable rather than something thorough that I will abandon.

I have already decided the broad direction; this is about the specifics.

What should I decide now, and what should I defer?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
TH
askedtyndall_haze38k3817 Apr 2024
7Is there a repeat draw, or is this a single value? One value is a point, not a trend. – dead_volume 2 months ago
6Which equation produced the eGFR? They disagree by enough to matter at the margins. – swirl_dont_shake 11 days ago
add a comment

5 Answers

Accepted answer first, then by votes
49

Accepted answer

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Headline results, principal programmes

TrialAgentnDurationPrimary result
STEP 1Semaglutide 2.4 mg1,96168 wk−14.9 % vs −2.4 % weight
STEP 2Semaglutide 2.4 mg, T2DM1,21068 wk−9.6 % vs −3.4 % weight
SURMOUNT-1Tirzepatide 5/10/15 mg2,53972 wk−15 / −19 / −21 % weight
SURMOUNT-4Tirzepatide, withdrawal67088 wkContinued loss vs substantial regain
SELECTSemaglutide 2.4 mg17,604~40 moMACE HR 0.80 (0.72–0.90)
FLOWSemaglutide 1.0 mg, CKD3,533~3.4 yrRenal composite reduced; stopped early
SURMOUNT-OSATirzepatide, OSA46952 wkAHI reduced with and without PAP

Worth being precise here: a twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
HV
answered · acceptedh_villanueva70k488 Aug 2024
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
43

The short version: a small, well-chosen panel with a baseline beats a large one without.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Research-use compounds are not approved for human use, and no panel makes that safer.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25828 Jul 2024
2Thank you — this is the answer I was looking for. – swirl_dont_shake 3 days ago
3Same laboratory every time is advice I ignored for a year, and the series was useless because of it. – dead_volume 2 months ago
add a comment
24

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Mechanically, delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

Decide the action for each result before you order the test.

edited 14 May 2024 by lipid_panel_q — added the method parameters

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12722 Apr 2024
18

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
DB
answeredDr_Ingrid_Baumgartner73k583 May 2024
17

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
HV
answeredh_villanueva70k4814 Jun 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.